Guangdong group that has pivoted from real estate and electrical products toward biomedicine, including transplant-related drugs.
Guangdong group that has pivoted from real estate and electrical products toward biomedicine, including transplant-related drugs.
Moat: none. Business model in transition from legacy operations to an unproven biomedicine pivot.
Headquarters: Guangdong, China · Employees: 1,438
Size Wedge Industrial (000534.SZ) is a China Real Estate company (Real Estate Development) with a market value of $1.16B, the 1899th largest of 4,790 China companies the cockpit tracks. Shares closed at CN¥15.34 on 18 Nov 2026.
Performance Over six months the shares fell 58.4%, against -8.8% for the median peer and -20.0% for the China market (cap-weighted) — 3rd lowest of 21 in its peer set.
Growth Revenue grew 4.1% over the last twelve months (peer median -2.7%); the operating margin is 9.7% (peer median 16.2%).
Valuation It trades at 29.4× forward earnings against a peer median of 17.1× (5th most expensive of 16).
Next results Next results expected around 27 Apr 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | CN¥1.29B | CN¥1.29B | CN¥1.08B | CN¥970M | CN¥787M |
| Revenue growth | — | +20% | +11% | +23% | — |
| Gross profit | CN¥937M | CN¥873M | CN¥754M | CN¥678M | CN¥576M |
| EBITDA | n/a | CN¥306M | CN¥330M | CN¥255M | CN¥198M |
| Net income | CN¥171M | CN¥197M | CN¥193M | CN¥177M | CN¥102M |
| Free cash flow | -CN¥247M | -CN¥317M | -CN¥472M | -CN¥295M | -CN¥146M |
| Capital expenditure | CN¥349M | CN¥430M | CN¥587M | CN¥391M | CN¥342M |
| Total debt | CN¥2.16B | CN¥2.19B | CN¥1.93B | CN¥1.16B | CN¥650M |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Wedge Industrial 000534.SZ | $1.16B | -58% | +4% | 10% | 29.4× | n/a |
| China Resources Sanjiu Medical & Pharmaceutical 000999.SZ | $6.59B | +6% | +4% | 14% | 13.2× | -6.2% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | 000534.SZ | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | -20.1% | -3.5% | 2nd lowest of 21 |
| 6-month return | -58.4% | -8.8% | 3rd lowest of 21 |
| Distance from 52-week high | -68.8% | -32.2% | 3rd lowest of 21 |
| Revenue growth (TTM) | +4.1% | -2.7% | 9th highest of 21 |
| Operating margin | 9.7% | 16.2% | 8th lowest of 21 |
| Forward P/E | 29.4× | 17.1× | 5th most expensive of 16 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Wedge Industrial 000534.SZ | China | $1.16B | -58% | +4% | 10% | 29.4× | n/a | n/a |
| SR Medical Technology 0108.HK | Hong Kong | $1.16B | +18% | +25% | 4% | n/a | n/a | n/a |
| Token 1766.T | Japan | $1.15B | +4% | +5% | 6% | 8.9× | n/a | n/a |
| Tosei 8923.T | Japan | $1.18B | +20% | +14% | 23% | 11.5× | n/a | n/a |
| Mainstreet Equity MEQ.TO | Canada | $1.14B | +6% | +5% | 60% | 18.6× | n/a | n/a |
| Opendoor Technologies OPEN | United States | $1.18B | -71% | -29% | -19% | n/a | n/a | n/a |
| Forestar FOR | United States | $1.14B | -14% | -2% | 13% | 9.8× | n/a | n/a |
| Art 0565.HK | Hong Kong | $1.19B | +15% | +51% | 60% | n/a | n/a | n/a |
| Frey FREY.PA | France | $1.19B | -2% | +45% | 49% | 22.5× | n/a | n/a |
| China Overseas Grand Oceans 0081.HK | Hong Kong | $1.20B | -10% | -3% | 5% | 18.3× | n/a | n/a |
| Ichigo 2337.T | Japan | $1.12B | -8% | -17% | 29% | 9.4× | n/a | n/a |
| Icade ICAD.PA | France | $1.22B | -28% | -9% | 17% | 5.1× | n/a | n/a |
| Red Star Macalline 1528.HK | Hong Kong | $1.11B | -35% | -3% | -24% | 30.1× | n/a | n/a |
| Tibet Urban Development & Investment 600773.SS | China | $1.09B | -63% | -78% | -124% | n/a | n/a | n/a |
| Seazen 1030.HK | Hong Kong | $1.24B | -34% | -35% | 16% | 11.7× | n/a | n/a |
| Sri Lotus Developers and Realty LOTUSDEV.NS | India | $1.24B | +71% | +40% | 38% | 33.8× | n/a | n/a |
| IRSA Inversiones y Representaciones SA Sponsored ADR IRS | United States | $1.08B | -17% | +9% | 42% | 59.0× | n/a | n/a |
| Shenzhen Zhenye (Group) 000006.SZ | China | $1.08B | -44% | -56% | 0% | n/a | n/a | n/a |
| Zhuhai Zhumian 600185.SS | China | $1.08B | -28% | -49% | 17% | 17.1× | n/a | n/a |
| AEDAS Homes AEDAS.MC | Spain | $1.07B | +2% | -25% | 10% | 9.1× | n/a | n/a |
| First Sponsor ADN.SI | Singapore | $1.07B | -7% | -8% | 22% | 315.0× | n/a | n/a |